Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10874677 Subcutaneously administered anti-IL-6 receptor antibody

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
January 22, 2019
Date of Patent
December 29, 2020
Patent Application Number
16254105
Patent Citations
‌
US Patent 10168326 Interference-suppressed immunoassay to detect anti-drug antibodies in serum samples
‌
US Patent 10231981 Subcutaneously administered anti-IL-6 receptor antibody for treatment of juvenile idiopathic arthritis
‌
US Patent 10316096 Stabilized antibody-containing formulations
‌
US Patent 10377794 Optimized method for antibody capturing by mixed mode chromatography
‌
US Patent 10501769 Method for the production of a glycosylated immunoglobulin
‌
US Patent 10590164 Method for preparing a composition comprising highly concentrated antibodies by ultrafiltration
‌
US Patent 10654888 Method for removing viruses in a physiologically-active protein-containing sample
‌
US Patent 10662245 Methods of reducing IL-6 activity for disease treatment
‌
US Patent 10744201 Method for treating rheumatoid arthritis with a human IL-6 receptor antibody and methotrexate
‌
US Patent 10717781 Neuroinvasion inhibitor
•••
Patent Citations Received
‌
US Patent 11667720 Subcutaneously administered anti-IL-6 receptor antibody
0
‌
US Patent 11622969 Subcutaneously administered anti-IL-6 receptor antibody
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10874677
Patent Primary Examiner
‌
Prema M Mertz

Find more entities like US Patent 10874677 Subcutaneously administered anti-IL-6 receptor antibody

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo